Merck
-
After several months of legal back-and-forth in the courtroom, with the FDA requesting up to 75 years to release all of their vaccine safety-related documents, a ...
-
The United States will soon roll out pills to treat patients with COVID-19. A second brand was authorized for emergency use Thursday. Just the day before, ...
-
The FDA is authorizing a second pill to treat COVID-19. How effective is it and who can get it? One Chinese city that’s larger than the Big ...
-
The Food and Drug Administration (FDA) on Thursday morning issued an emergency use authorization for Merck’s antiviral pill for COVID-19, more than 12 hours after giving the ...
-
Denmark on Thursday approved an antiviral COVID-19 drug produced by Merck and Ridgeback Biotherapeutics for at-risk patients with symptoms, including the elderly. The Scandinavian country became ...
-
Outside advisers to the U.S. Food and Drug Administration (FDA) on Tuesday narrowly voted to recommend the agency grant emergency use authorization (EUA) for a drug ...
-
A new analysis of clinical trial results shows that Merck’s antiviral pill for treating COVID-19 is significantly less effective than previously reported in October, the company ...
-
Britain’s medicines regulator has given a green light on Thursday to an antiviral COVID-19 pill jointly developed by U.S.-based Merck and partner Ridgeback Biotherapeutics. The drug, known ...
-
Merck has reached an agreement that will let other drug makers produce its COVID-19 pill, though many countries are excluded from the pact.
-
AMSTERDAM—The pharmaceutical company Merck says it has asked the European Medicines Agency to authorize its COVID-19 antiviral treatment, the first pill that has been shown to ...
-
The Bill & Melinda Gates Foundation will fund up to $120 million worth of an experimental drug that is used in treating COVID-19 to assist lower-income countries ...
-
A new COVID-19 pill that can purportedly cut the risk of both hospitalization as well as death from COVID-19—by as much as 50 percent—is now in ...
-
Merck is set to get $712 per treatment course for its COVID-19 pill from the U.S. government—even as it costs a fraction of that to produce, ...
-
Merck and its partner on Monday announced they filed an emergency use authorization application with the U.S. Food and Drug Administration (FDA) for their oral antiviral ...
-
Results from a clinical trial show that Merck’s antiviral pill for COVID-19 is effective, the company said Friday. The antiviral, molnupiravir, cut the risk of hospitalization ...
-
Pharmaceutical company Merck is requesting emergency use authorization for an experimental COVID-19 drug. It targets the CCP (Chinese Communist Party) virus’s ability to make copies of itself.
-
Inflation, a key indicator closely watched by the Fed, is still at historically high levels. Is it going to slow down growth going forward? Drugmaker Merck’s ...
-
Ken Frazier, the longtime chief executive of Merck and one of the few remaining Black CEOs of a Fortune 500 company, is retiring.
-
The U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD), will purchase an additional 100 million doses of COVID-19 investigational vaccine from ...